Rating History for Kymera Therapeutics (KYMR) by Canaccord

More Stocks Rated by Canaccord | Latest Ratings for KYMR
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
5/6/2026 Edward Nash New Coverage Buy
(N/A)		 106.00
(N/A)		 82.71
(99.75)		 20.6% Details